(0.22%) 5 307.00 points
(0.24%) 38 886 points
(0.27%) 18 642 points
(-0.29%) $76.77
(4.33%) $2.70
(-0.37%) $2 337.10
(-1.53%) $29.98
(-0.12%) $1 040.70
(0.01%) $0.921
(0.02%) $10.49
(0.00%) $0.785
(-0.45%) $90.02
Quarter results today
(bmo 2024-06-03)
Expected move: +/- 14.04%
Live Chart Being Loaded With Signals
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally...
Stats | |
---|---|
Today's Volume | 73 346.00 |
Average Volume | 178 420 |
Market Cap | 3.86M |
EPS | $0 ( 2024-04-03 ) |
Next earnings date | ( $0 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0500 |
ATR14 | $0.0430 (1.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Lazar David E. | Buy | 150 000 | Series E Convertible Preferred Stock |
2024-04-11 | Ben-tzvi Avraham | Buy | 100 000 | Common Stock |
2024-04-11 | Natan David | Buy | 100 000 | Common Stock |
2024-04-11 | Mcmurdo Matthew Charles | Buy | 100 000 | Common Stock |
2024-04-11 | Lazar David E. | Buy | 100 000 | Common Stock |
INSIDER POWER |
---|
-71.24 |
Last 97 transactions |
Buy: 3 573 408 | Sell: 6 921 404 |
Volume Correlation
OpGen Inc Correlation
10 Most Positive Correlations | |
---|---|
STLD | 0.908 |
PCAR | 0.869 |
MYRG | 0.854 |
SKIN | 0.834 |
TALK | 0.831 |
VIRX | 0.829 |
PKW | 0.827 |
DVLU | 0.823 |
GLSI | 0.823 |
PLYA | 0.823 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OpGen Inc Correlation - Currency/Commodity
OpGen Inc Financials
Annual | 2022 |
Revenue: | $2.61M |
Gross Profit: | $-816 698 (-31.32 %) |
EPS: | $-15.05 |
FY | 2022 |
Revenue: | $2.61M |
Gross Profit: | $-816 698 (-31.32 %) |
EPS: | $-15.05 |
FY | 2021 |
Revenue: | $4.31M |
Gross Profit: | $1.46M (33.85 %) |
EPS: | $-2.20 |
FY | 2020 |
Revenue: | $4.21M |
Gross Profit: | $365 950 (8.68 %) |
EPS: | $-1.660 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
OpGen Inc
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators